She Leads Biotech
Solving More Than Science with Adrienne Mendoza Cell and gene therapy is advancing rapidly, but science alone isn’t enough. In this episode of She Leads Biotech, Adrienne Mendoza, Chief Operating Officer of BBG Advanced Therapies, shares what’s really needed to move the field forward, from improving access and infrastructure to rethinking how these therapies reach patients. We also explore her journey over the past year, building a stronger presence in the industry, translating complex science for broader audiences, and the realities of leading through a challenging and evolving market. A practical and honest look at where the field is today, and what it will take to get to the next stage. Chapters 00:00 Introduction 02:00 Stepping into a New Role at BBG Advanced Therapies 05:00 How the Role of a COO Evolves 08:30 Building Presence and Community in CGT 12:00 Making Complex Science Understandable 16:00 The Mobile Leukapheresis Bus 21:00 Access Challenges in Cell & Gene Therapy 27:00 What Needs to Change in the System 33:00 Industry Challenges and Optimism 38:00 What the Next 5 Years Could Look Like 41:00 Life Outside of Biotech #SheLeadsBiotech #CellAndGeneTherapy #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch
80 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de She Leads Biotech!